These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24561509)

  • 1. Issues surrounding postoperative therapy in Crohn's disease to prevent recurrence.
    Morar P; Hart A; Warusavitarne J
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1763-4. PubMed ID: 24561509
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tumor necrosis factor therapy to prevent Crohn's disease recurrence after surgery.
    Herfarth HH
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1503-6. PubMed ID: 24534549
    [No Abstract]   [Full Text] [Related]  

  • 3. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply: To PMID 24440221.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1764-5. PubMed ID: 24956081
    [No Abstract]   [Full Text] [Related]  

  • 5. Biologics in peri-operative management of Crohn's disease.
    Hanauer SB
    Acta Gastroenterol Belg; 2001; 64(2):191-2. PubMed ID: 11475133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab vs adalimumab for Crohn's disease.
    Dhillon AS; Harris AW
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):210. PubMed ID: 24954114
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab vs adalimumab for Crohn's disease: perhaps too early to call it a tie.
    Dassopoulos T; Sorrentino D
    Clin Gastroenterol Hepatol; 2014 May; 12(5):818-20. PubMed ID: 24342747
    [No Abstract]   [Full Text] [Related]  

  • 8. Postoperative Crohn's disease: how can we prevent it?
    Swoger JM; Regueiro M
    Expert Rev Clin Immunol; 2010 Jul; 6(4):501-4. PubMed ID: 20594119
    [No Abstract]   [Full Text] [Related]  

  • 9. Postoperative infliximab and elemental diet combination in a case with diffuse, extensive jejunoileal Crohn's disease.
    Matsuda S; Bamba T; Sohma S; Yamamoto T
    Int J Colorectal Dis; 2014 Feb; 29(2):265-6. PubMed ID: 24150229
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record?
    Sorrentino D
    Inflamm Bowel Dis; 2012 Sep; 18(9):1624-5; author reply 1626-7. PubMed ID: 22359378
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
    Lichtenstein GR
    Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959
    [No Abstract]   [Full Text] [Related]  

  • 12. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
    Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
    Sorrentino D; Paviotti A
    Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of post-surgical recurrence of Crohn's disease. A perspective].
    Paviotti A; Terrosu G; Avellini C; Girometti R; Sorrentino D
    Recenti Prog Med; 2009 May; 100(5):233-8. PubMed ID: 19772213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab in Crohn's disease: early and long-term treatment.
    Armuzzi A; De Pascalis B; Fedeli P; De Vincentis F; Gasbarrini A
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S271-9. PubMed ID: 18599000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological compounds in the treatment of Crohn's disease].
    Dinari G
    Harefuah; 2001 Apr; 140(4):316-8. PubMed ID: 11303396
    [No Abstract]   [Full Text] [Related]  

  • 17. Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in Japan.
    Fukushima K; Sugita A; Futami K; Takahashi KI; Motoya S; Kimura H; Yoshikawa S; Kinouchi Y; Iijima H; Endo K; Hibi T; Watanabe M; Sasaki I; Suzuki Y;
    Surg Today; 2018 Jun; 48(6):584-590. PubMed ID: 29383596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply: To PMID 24530602.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1407. PubMed ID: 24614332
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease.
    Fraser GM
    Clin Gastroenterol Hepatol; 2010 Dec; 8(12):1099; author reply 1099-100. PubMed ID: 20728574
    [No Abstract]   [Full Text] [Related]  

  • 20. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.